Search

everythinglearnresearchcommunity

for

Search:↓

Cooling with antioxidants helps protect hair during chemotherapy.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Adenosine complex helps increase hair thickness and density in hair loss.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Alpinetin helps grow hair by turning on hair stem cells and is safe for use.

Silver nanoparticles may reduce chemotherapy side effects and improve cancer treatment.

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

Etoposide makes radiation therapy more effective against tumors without major side effects.

A man had a non-cancerous, fast-growing skin lump on his arm that was removed with surgery.

Upadacitinib may effectively treat alopecia areata without side effects.

The new microneedle treatment could be a more effective and convenient option for hair loss.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Photodynamic therapy successfully treated skin cancer in a 53-year-old woman.

Upadacitinib may cause hair loss.

Alopecia neoplastica is hair loss from breast cancer spreading to the scalp.

The nanoparticles show promise for cancer treatment and diagnosis with fewer side effects.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

The nanogel with Ciclopirox Olamine is a promising treatment for skin yeast infections.

New niosomal formulation effectively delivers aminexil through rat skin.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

DPCP may be safe for treating alopecia during pregnancy, but more research is needed.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.